James A. Ruggles

1.9k total citations
17 papers, 1.5k citations indexed

About

James A. Ruggles is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, James A. Ruggles has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in James A. Ruggles's work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (9 papers) and Pancreatic function and diabetes (5 papers). James A. Ruggles is often cited by papers focused on Diabetes Treatment and Management (10 papers), Diabetes Management and Research (9 papers) and Pancreatic function and diabetes (5 papers). James A. Ruggles collaborates with scholars based in United States, United Kingdom and Denmark. James A. Ruggles's co-authors include Orville Kolterman, Mark Fineman, Larry Z. Shen, Christian Weyer, David Maggs, Steve C. Schultz, Dennis Dong Hwan Kim, Alain Baron, Loretta L. Nielsen and Martin P. Horvath and has published in prestigious journals such as Cell, Journal of Molecular Biology and Diabetes Care.

In The Last Decade

James A. Ruggles

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A. Ruggles United States 14 956 574 549 330 200 17 1.5k
Maria Rasmussen Denmark 11 717 0.8× 258 0.4× 454 0.8× 295 0.9× 368 1.8× 13 1.1k
J Chapal France 21 319 0.3× 693 1.2× 326 0.6× 148 0.4× 81 0.4× 63 1.2k
Gérald van de Werve Canada 19 291 0.3× 300 0.5× 483 0.9× 341 1.0× 22 0.1× 33 1.1k
Tetsuo Matsui Japan 13 324 0.3× 246 0.4× 383 0.7× 106 0.3× 81 0.4× 25 884
G Hetenyi Canada 22 561 0.6× 341 0.6× 485 0.9× 708 2.1× 59 0.3× 100 1.5k
G M Grodsky United States 11 476 0.5× 566 1.0× 280 0.5× 111 0.3× 45 0.2× 15 877
Kim Andrews United States 17 286 0.3× 261 0.5× 325 0.6× 97 0.3× 42 0.2× 44 900
P D Whitton United Kingdom 12 217 0.2× 295 0.5× 344 0.6× 294 0.9× 32 0.2× 17 1.0k
Charles O. Watlington United States 20 528 0.6× 130 0.2× 396 0.7× 137 0.4× 53 0.3× 47 1.3k
Rosalba Senese Italy 23 599 0.6× 74 0.1× 692 1.3× 594 1.8× 25 0.1× 60 1.5k

Countries citing papers authored by James A. Ruggles

Since Specialization
Citations

This map shows the geographic impact of James A. Ruggles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Ruggles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Ruggles more than expected).

Fields of papers citing papers by James A. Ruggles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Ruggles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Ruggles. The network helps show where James A. Ruggles may publish in the future.

Co-authorship network of co-authors of James A. Ruggles

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Ruggles. A scholar is included among the top collaborators of James A. Ruggles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Ruggles. James A. Ruggles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Clegg, Lindsay E., Robert C. Penland, David W. Boulton, et al.. (2019). Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial. Cardiovascular Diabetology. 18(1). 138–138. 57 indexed citations
2.
Clegg, Lindsay E., Robert C. Penland, David W. Boulton, et al.. (2019). 6-LB: Effect of Open-Label SGLT2 Inhibitor Treatment When Combined with Exenatide on Cardiovascular and Renal Outcomes in EXSCEL. Diabetes. 68(Supplement_1). 1 indexed citations
3.
Frías, Juan P., Samer Nakhle, James A. Ruggles, et al.. (2016). Exenatide once weekly improved 24‐hour glucose control and reduced glycaemic variability in metformin‐treated participants with type 2 diabetes: a randomized, placebo‐controlled trial. Diabetes Obesity and Metabolism. 19(1). 40–48. 23 indexed citations
4.
Kolterman, Orville, Dennis Dong Hwan Kim, Larry Z. Shen, et al.. (2005). Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. American Journal of Health-System Pharmacy. 62(2). 173–181. 354 indexed citations
5.
Ceriello, Antonio, Ludovica Piconi, Lisa Quagliaro, et al.. (2005). Effects of Pramlintide on Postprandial Glucose Excursions and Measures of Oxidative Stress in Patients With Type 1 Diabetes. Diabetes Care. 28(3). 632–637. 59 indexed citations
6.
Maggs, David, Mark Fineman, Sherwyn Schwartz, et al.. (2004). Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose‐timing study. Diabetes/Metabolism Research and Reviews. 20(1). 55–60. 61 indexed citations
7.
Ruggles, James A., et al.. (2004). Emerging therapies: controlling glucose homeostasis, immunotherapy, islet transplantation, gene therapy, and islet cell neogenesis and regeneration. Endocrinology and Metabolism Clinics of North America. 33(1). 239–252. 10 indexed citations
8.
Hollander, Priscilla, David Maggs, James A. Ruggles, et al.. (2004). Effect of Pramlintide on Weight in Overweight and Obese Insulin‐Treated Type 2 Diabetes Patients. Obesity Research. 12(4). 661–668. 141 indexed citations
9.
Amiel, Stephanie A., Simon Heller, Ian Macdonald, et al.. (2004). The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin‐induced hypoglycaemia in patients with type 1 diabetes. Diabetes Obesity and Metabolism. 7(5). 504–516. 19 indexed citations
10.
Weyer, Christian, Alan Gottlieb, Dennis Dong Hwan Kim, et al.. (2003). Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes. Diabetes Care. 26(11). 3074–3079. 80 indexed citations
11.
Peersen, Olve B., James A. Ruggles, & Steve C. Schultz. (2002). Dimeric structure of the Oxytricha nova telomere end-binding protein α-subunit bound to ssDNA. Nature Structural Biology. 9(3). 182–7. 38 indexed citations
12.
Whitehouse, Fred W., Davida Kruger, Mark Fineman, et al.. (2002). A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes. Diabetes Care. 25(4). 724–730. 212 indexed citations
13.
Ratner, Robert E., Laura L. Want, Mark Fineman, et al.. (2002). Adjunctive Therapy with the Amylin Analogue Pramlintide Leads to a Combined Improvement in Glycemic and Weight Control in Insulin-Treated Subjects with Type 2 Diabetes. Diabetes Technology & Therapeutics. 4(1). 51–61. 131 indexed citations
14.
Classen, Scott, James A. Ruggles, & Steve C. Schultz. (2001). Crystal structure of the N-terminal domain of Oxytricha nova telomere end-binding protein α subunit both uncomplexed and complexed with telomeric ssDNA. Journal of Molecular Biology. 314(5). 1113–1125. 38 indexed citations
15.
Horvath, Martin P., et al.. (1998). Crystal Structure of the Oxytricha nova Telomere End Binding Protein Complexed with Single Strand DNA. Cell. 95(7). 963–974. 211 indexed citations
16.
Ruggles, James A., Michele Nemecek-Marshall, & Ray Fall. (1993). Kinetics of appearance and disappearance of classes of bacterial ice nuclei support an aggregation model for ice nucleus assembly. Journal of Bacteriology. 175(22). 7216–7221. 28 indexed citations
17.
Mitchell, Peter G., James A. Ruggles, Joseph Sneddon, & Leon J. Radziemski. (1985). Direct Determination of Copper in Solids and Ores by Laser Ablation-Direct Current Argon Plasma Emission Spectrometry. Analytical Letters. 18(14). 1723–1732. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Rasmussen Breakdown of academic impact, for papers by J Chapal Breakdown of academic impact, for papers by Gérald van de Werve Breakdown of academic impact, for papers by Tetsuo Matsui Breakdown of academic impact, for papers by G Hetenyi Breakdown of academic impact, for papers by G M Grodsky Breakdown of academic impact, for papers by Kim Andrews Breakdown of academic impact, for papers by P D Whitton Breakdown of academic impact, for papers by Charles O. Watlington Breakdown of academic impact, for papers by Rosalba Senese
Rankless by CCL
2026